Scilex Holding Company (Nasdaq: SCLX) is an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain and to become the global pain management leader committed to social, environmental, economic, and ethical principles to responsibly develop pharmaceutical products to maximize quality of life.
Investors 1
| Date | Name | Website |
| - | Frazier Li... | frazierls.... |
Mentions in press and media 6
| Date | Title | Description | Source |
| 25.04.2024 | Scilex Holding Company Announces Closing of $15 Million Regi... | - | globenewsw... |
| 24.04.2024 | Scilex Holding Company Announces $15 Million Registered Dire... | - | globenewsw... |
| 05.03.2024 | Scilex Holding Company Announces Closing of $10 Million Boug... | - | globenewsw... |
| 29.02.2024 | Scilex Holding Company Announces $10 Million Bought Deal Off... | PALO ALTO, Calif., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” ... | einpresswi... |
| 29.02.2024 | Scilex Holding Company Announces $10 Million Bought Deal Off... | - | globenewsw... |
| 05.02.2023 | Scilex Holding Company, a majority-owned subsidiary of Sorre... | PALO ALTO, Calif., Feb. 04, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company SCLX "Scilex")... | einpresswi... |